Handling and Staging of Renal Cell Carcinoma: The International Society of Urological Pathology Consensus (ISUP) Conference Recommendations
暂无分享,去创建一个
B. Delahunt | D. Grignon | H. Samaratunga | J. Srigley | L. Egevad | P. Tamboli | M. Amin | R. Montironi | K. Trpkov | S. Bonsib | A. Billis | A. López-Beltran
[1] Lars Egevad,et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia , 2013, The American journal of surgical pathology.
[2] B. Delahunt,et al. International Society of Urological Pathology (ISUP) consensus conference on renal neoplasia: rationale and organization. , 2013, The American journal of surgical pathology.
[3] B. Delahunt,et al. Renal Tumors: Diagnostic and Prognostic Biomarkers , 2013, The American journal of surgical pathology.
[4] J. Cheville,et al. The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters , 2013, The American journal of surgical pathology.
[5] J. Milner,et al. Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat. , 2013, Archives of pathology & laboratory medicine.
[6] B. Shuch,et al. The surgical approach to multifocal renal cancers: hereditary syndromes, ipsilateral multifocality, and bilateral tumors. , 2012, The Urologic clinics of North America.
[7] Liang Cheng,et al. Lymphadenectomy in urologic oncology: pathologic considerations. , 2011, The Urologic clinics of North America.
[8] C. Compton,et al. TNM seventh edition: What's new, what's changed , 2010, Cancer.
[9] C. de Bazelaire,et al. Hereditary renal cancer syndromes: an update of a systematic review. , 2010, European urology.
[10] F. Montorsi,et al. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? , 2010, European urology.
[11] B. Delahunt,et al. Renal Cell Neoplasms of Oncocytosis Have Distinct Morphologic, Immunohistochemical, and Cytogenetic Profiles , 2010, The American journal of surgical pathology.
[12] D. de Jong,et al. Hereditary causes of kidney tumours , 2010, European journal of clinical investigation.
[13] J. Cheville,et al. Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort. , 2010, The Journal of urology.
[14] A. Renshaw,et al. Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin. , 2010, Archives of pathology & laboratory medicine.
[15] B. Delahunt. Advances and controversies in grading and staging of renal cell carcinoma , 2009, Modern Pathology.
[16] J. Brooks,et al. Recommendations for the reporting of surgically resected specimens of renal cell carcinoma: the Association of Directors of Anatomic and Surgical Pathology. , 2009, Human pathology.
[17] C. Lohse,et al. Multifocal Renal Cell Carcinoma: Clinicopathologic Features and Outcomes for Tumors ≤4 cm , 2008, Advances in urology.
[18] S. Bonsib. Macroscopic assessment, dissection protocols and histologic sampling strategy for renal cell carcinomas , 2008 .
[19] A. Villers,et al. Renal vein ostium wall invasion of renal cell carcinoma with an inferior vena cava tumor thrombus: prediction by renal and vena caval vein diameters and prognostic significance. , 2008, The Journal of urology.
[20] J. Cheville,et al. Patients With pT1 Renal Cell Carcinoma Who Die From Disease After Nephrectomy May Have Unrecognized Renal Sinus Fat Invasion , 2007, The American journal of surgical pathology.
[21] F. Algaba,et al. What does the urologist expect from the pathologist (and what can the pathologists give) in reporting on adult kidney tumour specimens? , 2007, European urology.
[22] J. Patard,et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] D. Grignon,et al. Renal Cell Carcinoma and the Renal Sinus , 2007, Advances in anatomic pathology.
[24] S. Bonsib. Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases , 2006, Modern Pathology.
[25] H. Moch,et al. Spectrum of Epithelial Neoplasms in End-Stage Renal Disease: An Experience From 66 Tumor-Bearing Kidneys With Emphasis on Histologic Patterns Distinct From Those in Sporadic Adult Renal Neoplasia , 2006, The American journal of surgical pathology.
[26] J. Cheville,et al. Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? , 2005, The Journal of urology.
[27] S. Bonsib. T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas. , 2005, The Journal of urology.
[28] F. Guillé,et al. Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma , 2005, Cancer.
[29] F. Marshall. The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas. , 2005, The Journal of urology.
[30] D. Grignon,et al. Handling and reporting of tumor-containing kidney specimens. , 2005, Clinics in laboratory medicine.
[31] J. Cheville,et al. Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma. , 2005, The Journal of urology.
[32] J. Cheville,et al. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? , 2005, The Journal of urology.
[33] S. Fleming,et al. Best Practice No 180 Nephrectomy for renal tumour; dissection guide and dataset , 2004, Journal of Clinical Pathology.
[34] J. Cheville,et al. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. , 2004, Urology.
[35] F. Algaba,et al. Handling and pathology reporting of renal tumor specimens. , 2004, European urology.
[36] M. Kattan,et al. Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival. , 2004, The Journal of urology.
[37] V. Ficarra,et al. Tumor-size breakpoint for prognostic stratification of localized renal cell carcinoma. , 2004, Urology.
[38] J. Cheville,et al. Solid renal tumors: an analysis of pathological features related to tumor size. , 2003, The Journal of urology.
[39] A. Sagalowsky,et al. Reassessment of the 1997 TNM classification system for renal cell carcinoma , 2003, Cancer.
[40] J. Srigley,et al. Protocol for the examination of specimens from patients with Wilms tumor (nephroblastoma) or other renal tumors of childhood. , 2003, Archives of pathology & laboratory medicine.
[41] D. Griffiths,et al. Evaluation of a protocol for examining nephrectomy specimens with renal cell carcinoma , 2003, Journal of clinical pathology.
[42] J. Cheville,et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma , 2003, Cancer.
[43] R. Figlin,et al. TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. , 2003, The Journal of urology.
[44] E. Castelli,et al. The number of lymph nodes examined and staging accuracy in renal cell carcinoma , 2003, BJU international.
[45] R. Figlin,et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] Matthew P. Rutman,et al. Clinical and pathologic tumor size in renal cell carcinoma; difference, correlation, and analysis of the influencing factors. , 2002, Urology.
[47] B. Delahunt,et al. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma , 2002, Cancer.
[48] M. Kattan,et al. A postoperative prognostic nomogram for renal cell carcinoma. , 2001, The Journal of urology.
[49] R. Figlin,et al. Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome. , 2001, The Journal of urology.
[50] H. Ito,et al. The impact of a 4 cm. cutoff point for stratification of T1N0M0 renal cell carcinoma after radical nephrectomy. , 2001, The Journal of urology.
[51] H. Moch,et al. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma , 2000, Cancer.
[52] D. Govender. The pathology of nephroblastoma , 2000 .
[53] S. Bonsib,et al. Renal sinus involvement in renal cell carcinomas. , 2000, The American journal of surgical pathology.
[54] M. Rubin,et al. Renal oncocytosis: a morphologic study of fourteen cases. , 1999, The American journal of surgical pathology.
[55] C. Zuppan. Handling and evaluation of pediatric renal tumors. , 1998, American journal of clinical pathology.
[56] J. Eble. Recommendations for examining and reporting tumor-bearing kidney specimens from adults. , 1998, Seminars in diagnostic pathology.
[57] J. Beckwith,et al. National Wilms Tumor Study: An Update for Pathologists , 1998, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[58] A. Pathology,et al. Recommendations for the reporting of resected neoplasms of the kidney , 1996, Virchows Archiv.
[59] J. Cheville,et al. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. , 2011, European urology.
[60] D. Jacqmin,et al. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. , 2009, European urology.
[61] B. Ljungberg. Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881 , 2009 .
[62] S. Bonsib. Renal veins and venous extension in clear cell renal cell carcinoma , 2007, Modern Pathology.
[63] M. Kattan,et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. , 2005, The Journal of urology.
[64] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.